Journal of the Korean Association of Oral and Maxillofacial Surgeons

The Korean Association of Oral and Maxillofacial Surgeons (대한구강악안면외과학회)
권호 표지

THE PET/CT IN THE DIAGNOSIS OF ORAL CANCER: CLINICAL CASES

구강암의 진단에 사용되어지는 PET/CT: 임상 증례

  • Kim, Sung-Jin (Department of Oral and Maxillofacial Surgery, Korea Cancer Center Hospital) ;
  • Kim, Yong-Kack (Department of Oral and Maxillofacial Surgery, Korea Cancer Center Hospital) ;
  • Kim, Chul (Department of Oral and Maxillofacial Surgery, Eulji University Hospital)
  • 김성진 (원자력병원 치과 구강악안면외과) ;
  • 김용각 (원자력병원 치과 구강악안면외과) ;
  • 김철 (을지대학병원 치과 구강악안면외과)
  • Published : 2005.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

With the development of systemic diagnostic technique in cancer, the diagnostic methods of head and neck region are developing, also. Now, it is usually used computed tomography(CT), magnetic resornance image(MRI) in head and neck cancer and positron emission tomography(PET) is being increased in diagnostic use because of tumor specificity and accuracy. However, CT and MRI show the advantage of showing precise anatomical landmarks, but the disadvantage of these methods is much affecting by anatomical variations and changes. Otherwise, PET presents the imaging of physiologic and biochemical phenomenon and the disadvantage is the difficult differentiation of normal physiologic uptake, the lack of normal anatomical landmarks. PET/CT, the combination of clinical PET and CT imaging in a single unit is introduced recently, and it helps to get more accurate diagnostic interpretation and to improve in evaluating response to therapy, in management of patients with malignant tumors. So, we report the advantages of PET/CT in the diagnosis of oral cancer with review of literatures.

Keywords

References

  1. Smith TA: FDG uptake, tumor characteristics and response to therapy: a review. Nucl Med Commun 1998;19(2):69-82
  2. Paul G, Kluetz, Carolyn Cidis Meltzer, et al: Combined PET/CT Imaging in Oncology: Impact on Patient Management. Clinical Positron Imaging 2000;3:223-230 https://doi.org/10.1016/S1095-0397(01)00055-3
  3. Dwamena BA, Sonnad SS, Angobaldo JO, et al: Metastases from non-small cell lung cancer. Mediastinal staging in the 1990s. Metaanalytic comparison of PET and CT. Radiology 1999;213:530-536 https://doi.org/10.1148/radiology.213.2.r99nv46530
  4. Gupta NC, Tamim WJ, Graeber GG, et al: Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest 2001;120:521- 527 https://doi.org/10.1378/chest.120.2.521
  5. Hawighorst H, Knapstein PG, Weikel W, et al: Invasive cervix carcinoma( pT2b-pT4a). Value of conventional and pharmacokinetic magnetic resornance image(MRI) in comparison with extensive cross section and histopathologic findings. Radiologe 1997;37:130-138 https://doi.org/10.1007/s001170050185
  6. Maier AG, Kersting-Sommerhoff B, Reeders JW, et al: Staging of rectal cancer by double-contrast MR imaging using the rectally administered superparamagnetic iron oxide contrast agent ferristene and IV gadodiamde injection. Results of a multicenter phase II trial. J Magn Reson Imaging 2000;12:651-660 https://doi.org/10.1002/1522-2586(200011)12:5<651::AID-JMRI1>3.0.CO;2-R
  7. Block MI, Patterson GA, Sundaresan RS, et al: Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 1997;64:770-777 https://doi.org/10.1016/S0003-4975(97)00619-X
  8. Czernin J, Phelps ME: Positron emission tomography scanning. Current and future applications. Ann Rev Med 2002;53:89-112 https://doi.org/10.1146/annurev.med.53.082901.104028
  9. Engel H, Steinert H, Buck A, Berthold T, Huch Boni RA, von Schulthess GK: Whole-body PET:physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med 1996;37(3):441-446
  10. Shreve PD, Anzai Y, Wahl RL: Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19(1):61-77;quiz 150-151 https://doi.org/10.1148/radiographics.19.1.g99ja0761
  11. Vansteenkiste JF, Stroobants SG, Dupont PJ, et al: FDG-PET scan in potentially operable non-small lung cancer: do anatometabolic PETCT fusion images improve the localization of regional lymph node metastases? The Leuven Lung Cancer Group. Eur J Nucl Med 1998;25(11):1495-1501 https://doi.org/10.1007/s002590050327
  12. Townsend DW, Beyer T, Kinahan PE, et al: Recent studies with a combined PET/CT scanner. International Congress Series, 24th-26th September 1999, Hokkaido, Japan. Amsterdam: Elsevier Science B.V. p 229-244
  13. Uematsu H, Sadato N, Yonekura Y, et al: Coregistration of FDG PET and MRI of the head and neck using normal distribution of FDG. J Nucl Med 1998;39(12):2121-2127
  14. I. Frank Ciernik, Elena Dizendorf, Brigitta G, et al: Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasiblity study. Int J Radiation Oncology Biol Phys 2003;57:853-863 https://doi.org/10.1016/S0360-3016(03)00346-8